Distribution of human embryonic stem cell lines: who, when, and where.
作者信息
McCormick Jennifer B, Owen-Smith Jason, Scott Christopher Thomas
机构信息
Division of General Internal Medicine, Program in Professionalism and Bioethics, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Cell Stem Cell. 2009 Feb 6;4(2):107-10. doi: 10.1016/j.stem.2009.01.002.
Abstract
摘要
相似文献
1
Distribution of human embryonic stem cell lines: who, when, and where.
Cell Stem Cell. 2009 Feb 6;4(2):107-10. doi: 10.1016/j.stem.2009.01.002.
2
New administration likely to bring change to stem cell research.
Cell Stem Cell. 2009 Feb 6;4(2):111-2. doi: 10.1016/j.stem.2009.01.011.
3
Science aside: the trajectory of embryonic stem cell research in the USA.
Drug Discov Today. 2007 Apr;12(7-8):269-71. doi: 10.1016/j.drudis.2007.02.011. Epub 2007 Mar 1.
4
Embryonic stem cell research: a decade of debate from Bush to Obama.
Yale J Biol Med. 2009 Sep;82(3):101-3.
5
Human embryonic stem cell research: an Australian perspective.
Cell. 2007 Jan 26;128(2):221-3. doi: 10.1016/j.cell.2007.01.008.
6
Connecticut's continuing role in advancing stem cell research.
Yale J Biol Med. 2009 Sep;82(3):97-9.
7
NerveCenter: Embryonic stem cell challenges complicate adult cell research.
Ann Neurol. 2010 Dec;68(6):A12-3. doi: 10.1002/ana.22328.
8
Korea's accelerating stem-cell work prompts calls for global ethical rules.
Nature. 2005 May 26;435(7041):393. doi: 10.1038/435393a.
9
Power-laws and the use of pluripotent stem cell lines.
PLoS One. 2013;8(1):e52068. doi: 10.1371/journal.pone.0052068. Epub 2013 Jan 2.
10
A long way to go..
Nat Immunol. 2009 Oct;10(10):1035. doi: 10.1038/ni1009-1035.
引用本文的文献
1
Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials.
Stem Cell Reports. 2018 Aug 14;11(2):485-496. doi: 10.1016/j.stemcr.2018.06.012. Epub 2018 Jul 19.
2
Legal agreements and the governance of research commons: lessons from materials sharing in mouse genomics.
OMICS. 2014 Apr;18(4):254-73. doi: 10.1089/omi.2013.0158. Epub 2014 Feb 19.
3
Patents and misplaced angst: lessons for translational stem cell research from genomics.
Cell Stem Cell. 2013 May 2;12(5):508-12. doi: 10.1016/j.stem.2013.04.015.
4
Power-laws and the use of pluripotent stem cell lines.
PLoS One. 2013;8(1):e52068. doi: 10.1371/journal.pone.0052068. Epub 2013 Jan 2.
5
Scope and impact of international research in human pluripotent stem cells.
Stem Cell Rev Rep. 2012 Dec;8(4):1048-55. doi: 10.1007/s12015-012-9409-0.
6
The race is on: human embryonic stem cell research goes global.
Stem Cell Rev Rep. 2012 Dec;8(4):1043-7. doi: 10.1007/s12015-012-9391-6.
7
Tracking and assessing the rise of state-funded stem cell research.
Nat Biotechnol. 2010 Dec;28(12):1246-8. doi: 10.1038/nbt1210-1246.
8
The practical consequences of a national human embryonic stem cell registry.
Stem Cell Rev Rep. 2009 Dec;5(4):315-8. doi: 10.1007/s12015-009-9091-z. Epub 2009 Sep 2.
9
And then there were two: use of hESC lines.
Nat Biotechnol. 2009 Aug;27(8):696-7. doi: 10.1038/nbt0809-696.
10
Policy interoperability in stem cell research: demystifying harmonization.
Stem Cell Rev Rep. 2009 Jun;5(2):108-15. doi: 10.1007/s12015-009-9067-z. Epub 2009 Mar 31.
本文引用的文献
1
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell. 2007 Nov 30;131(5):861-72. doi: 10.1016/j.cell.2007.11.019.
2
Induced pluripotent stem cell lines derived from human somatic cells.
Science. 2007 Dec 21;318(5858):1917-20. doi: 10.1126/science.1151526. Epub 2007 Nov 20.
3
Proposition 71 and CIRM--assessing the return on investment.
Nat Biotechnol. 2007 May;25(5):513-21. doi: 10.1038/nbt0507-513.
4
Embryonic stem cell research and U.S. policy.
Stem Cells. 2006 Jun;24(6):1412-3. doi: 10.1634/stemcells.2006-0279. Epub 2006 May 10.
Zotero 插件